{"id":"W4300865296","doi":"10.1016/s1569-1993(22)01351-0","title":"661 The PDE4 inhibitor apremilast enhances benefits of cystic fibrosis transmembrane conductance regulator modulators in vitro and in vivo","year":2022,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; Cystic Fibrosis Foundation; University of Alabama; Sanofi; Cystic Fibrosis Foundation Therapeutics; Cystic Fibrosis Canada","keywords":"Apremilast; Medicine; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; In vivo; Regulator; In vitro; Pharmacology; Internal medicine; Biochemistry; Biology; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002628133,0.0004724672,0.0006631507,0.0002779308,0.0002650882,0.0006023005,0.0002195438,0.0007508658,0.006018747],"category_scores_gemma":[0.0002361268,0.0002609409,0.0004449441,0.0001966737,0.0003609503,0.0004542397,0.0002228469,0.001938201,0.001413032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000206403,"about_ca_system_score_gemma":0.0004244721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006535735,"about_ca_topic_score_gemma":0.001184513,"domain_scores_codex":[0.9997464,0.00005898306,0.00001882039,0.00003680731,0.00005911297,0.00007993745],"domain_scores_gemma":[0.9998203,0.00004252336,0.00003109691,0.00001755896,0.00001662998,0.0000718813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007253836,0.0009327756,0.0002135636,0.0002260171,0.00005030591,0.0001532134,0.0000407783,0.000279893,0.9808131,0.0002301101,0.00162295,0.008183495],"study_design_scores_gemma":[0.001384141,0.01820307,0.01003385,0.00005287905,0.0001564534,0.000456665,0.000248474,0.001649766,0.954309,0.0003409318,0.01312426,0.00004046135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976785,0.006844284,0.001477751,0.001381517,0.0006774424,0.00008132518,0.001727501,0.0003070875,0.01071806],"genre_scores_gemma":[0.9836931,0.003502518,0.001232477,0.0004819797,0.0001521163,0.00006894134,0.001821853,0.00004980408,0.008997346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006018747,"threshold_uncertainty_score":0.02013475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01086279326774084,"score_gpt":0.2574382647768217,"score_spread":0.2465754715090809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}